OOIR: Observatory of International Research

Papers

(The H4-Index of Advanced Drug Delivery Reviews is 86. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology	676
Editorial board members	611
Drug delivery for metabolism targeted cancer immunotherapy	370
Deciphering albumin-directed drug delivery by imaging	292
MIDD in Japan– Implementations, challenges and opportunities	289
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine	282
Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses	280
Penetration and translocation of functional inorganic nanomaterials into biological barriers	244
Liposomal formulations for treating lysosomal storage disorders	241
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art	240
Nanoparticle-neutrophils interactions for autoimmune regulation	232
MicroRNAs and their delivery in diabetic fibrosis	228
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria	189
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders	186
Tools for computational design and high-throughput screening of therapeutic enzymes	186
Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity	186
Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond	170
Emerging antibiotic alternatives: From antimicrobial peptides to bacteriophage therapies	164
Therapeutic and delivery strategies of phytoconstituents for renal fibrosis	161
Recent advances in endocrine organoids for therapeutic application	153
Models to study basic and applied aspects of lysosomal storage disorders	149
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles	141
Long-acting inhaled medicines: Present and future	141
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound	141
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity	139

Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies	137
Nanovaccines with cell-derived components for cancer immunotherapy	136
Bacterially mediated drug delivery and therapeutics: Strategies and advancements	133
Biopharmaceutical drug delivery and phototherapy using protein crystals	133
Editorial/Preface	131
Emerging Voices in Drug Delivery – Harnessing and Modulating Complex Biological Systems (Issue 2)	129
Targeting microbiome, drug metabolism, and drug delivery in oncology	129
From cells to subcellular organelles: Next-generation cancer therapy based on peptide self-assembly	128
Activatable dual-functional molecular agents for imaging-guided cancer therapy	127
Phytonanomaterials as therapeutic agents and drug delivery carriers	126
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers	125
In situ cellular hitchhiking of nanoparticles for drug delivery	125
Novel strategies for modulating the gut microbiome for cancer therapy	124
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications	124
In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols	123
Solid implantable devices for sustained drug delivery	123
Editorial Board	123
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics	119
3D printing of drug delivery systems enhanced with micro/nano-technology	118
Ultrasonic particles: An approach for targeted gene delivery	115
Activatable fluorescent probes for real-time imaging-guided tumor therapy	114
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders	114
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer	113
Synthetic biology-guided design and biosynthesis of protein polymers for delivery	112
Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems	111
Drug delivery using gold nanoparticles	111
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease	111
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases	111
Strategies to develop polymeric microneedles for controlled drug release	111
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches	110
Lysosomal therapies and drug delivery strategies: An overview	109
Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery	109
Drug delivery strategies for management of women’s health issues in the upper genital tract	106
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control	106
Technological and translational challenges for extracellular vesicle in therapy and diagnosis	105
In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities	104
Soft nano and microstructures for the photomodulation of cellular signaling and behavior	104
Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases	103
Engineering complexity in human tissue models of cancer	98
Tumour extravasation of nanomedicine: The EPR and alternative pathways	98
Light sheet fluorescence microscopy for monitoring drug delivery: Unlocking the developmental phases of embryos	98
Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective	97
Modular design principle based on compartmental drug delivery systems	97
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies	96
Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives	96
Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers	94
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors	93
Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy	93
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer	92
Novel drug delivery systems for the management of dry eye	91

High-throughput proteomics and AI for cancer biomarker discovery	91
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system	90
Model-informed precision dosing: State of the art and future perspectives	90
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives	89
Nanobodies: Robust miniprotein binders in biomedicine	89
The extracellular matrix of hematopoietic stem cell niches	88
Unignored intracellular journey and biomedical applications of extracellular vesicles	88
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers	87
Fit and forget: The future of dental implant therapy via nanotechnology	87
Editorial board members	86
Preface: Image-assisted organoid research and application	86
Editorial board members	86
Corrigendum to ‘Cell-penetrating peptides in protein mimicry and cancer therapeutics’ [Advanced Drug Delivery Reviews, 180 (2022), 114044]	86
Corrigendum to “Editorial: Advanced strategies to bridge the gap between inflammation and tissue regeneration” [Adv. Drug Deliv. Rev. 209 (2024) 115328]	86
Editorial board members	86